These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6968500)

  • 1. Complete adenosine deaminase (ADA) deficiency without immunodeficiency, and primary hyperoxaluria, in a 12-year-old boy.
    Perignon JL; Hamet M; Cartier P; Griscelli C
    Adv Exp Med Biol; 1980; 122A():403-8. PubMed ID: 6968500
    [No Abstract]   [Full Text] [Related]  

  • 2. New perspectives in the diagnosis and treatment of adenosine deaminase (ADA) deficiency.
    Levinsky RJ; Davies EG; Simmonds HA; Webster DR; Adinolfi M
    Adv Exp Med Biol; 1984; 165 Pt A():33-8. PubMed ID: 6609527
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological failure caused by adenosine deaminase deficiency].
    Sylwestrowicz T; Gruchalska E
    Acta Haematol Pol; 1979; 10(3):205-10. PubMed ID: 116467
    [No Abstract]   [Full Text] [Related]  

  • 4. Adenosine deaminase deficiency and severe combined immunodeficiency disease.
    Thompson LF; Seegmiller JE
    Adv Enzymol Relat Areas Mol Biol; 1980; 51():167-210. PubMed ID: 6255772
    [No Abstract]   [Full Text] [Related]  

  • 5. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
    Carson DA; Kaye J
    Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency.
    Cowan MJ; Martin DW; Wara DW; Ammann AJ
    Adv Exp Med Biol; 1984; 165 Pt A():39-45. PubMed ID: 6609530
    [No Abstract]   [Full Text] [Related]  

  • 7. Nucleotide metabolism in cultured T cells and in cells of patients deficient in adenosine deaminase and purine nucleoside phosphorylase.
    Cohen A; Gudas LJ; Ullman B; Martin DW
    Ciba Found Symp; 1978; (68):101-14. PubMed ID: 115659
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlations between purine levels, clinical and immunological status in ADA deficiency.
    Simmonds HA; Fairbanks LD; Morris GS; Hugh-Jones K; Morgan G; Levinsky RJ
    Adv Exp Med Biol; 1986; 195 Pt A():93-9. PubMed ID: 3728190
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary hyperoxaluria and adenosine deaminase deficiency without immunodeficiency.
    Perignon JL; Hamet M; Broyer M; Griscelli C; Lenoir G; Cartier P
    Int J Pediatr Nephrol; 1980 Mar; 1(1):26-9. PubMed ID: 7343525
    [No Abstract]   [Full Text] [Related]  

  • 10. Purine metabolism and immunodeficiency: urinary purine excretion as a diagnostic screening test in adenosine deaminase and purine nucleoside phosphorylase deficiency.
    Simmonds HA; Sahota A; Potter CF; Cameron JS
    Clin Sci Mol Med; 1978 May; 54(5):579-84. PubMed ID: 108044
    [No Abstract]   [Full Text] [Related]  

  • 11. Adenosine deaminase (ADA) and other enzyme abnormalities in immune deficiency states.
    Goldblum RM; Schmalstieg FC; Nelson JA; Mills GC
    Birth Defects Orig Artic Ser; 1978; 14(6A):73-84. PubMed ID: 215243
    [No Abstract]   [Full Text] [Related]  

  • 12. Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean.
    Giblett ER
    Ciba Found Symp; 1978; (68):3-18. PubMed ID: 115664
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of adenosine on mitogenesis of ADA-deficient lymphocytes.
    Uberti J; Lightbody JJ; Wolf JW; Anderson JA; Reid RH; Johnson RM
    Clin Immunol Immunopathol; 1978 Aug; 10(4):446-58. PubMed ID: 688701
    [No Abstract]   [Full Text] [Related]  

  • 14. Progress in understanding the mechanism of immunodeficiency disease associated with defects in purine metabolism.
    Seegmiller JE
    Monogr Hum Genet; 1978; 10():88-91. PubMed ID: 102926
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytidine deaminase deficiency in a child with combined immunodeficiency: more than a coincidence?
    Pérignon JL; Le Deist F; Arenzana-Seisdedos F; Thuillier L; Fischer A; Cartier P; Griscelli C
    Adv Exp Med Biol; 1986; 195 Pt A():129-35. PubMed ID: 2425563
    [No Abstract]   [Full Text] [Related]  

  • 16. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
    Simmonds HA; Panayi GS; Corrigall V
    Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition of adenosine deaminase deficient peripheral blood lymphocytes and lymphoid line cells by deoxyadenosine and adenosine.
    Hirschhorn R; Bajaj S; Borkowsky W; Kowalski A; Hong R; Rubinstein A; Papageorgiou P
    Cell Immunol; 1979 Feb; 42(2):418-23. PubMed ID: 311698
    [No Abstract]   [Full Text] [Related]  

  • 18. S-Adenosylhomocysteine hydrolase activity in a lymphoblastoid cell line from a patient with adenosine deaminase dificiency disease.
    Tsuchiya S; Nakae S; Konno T; Tada K
    J Inherit Metab Dis; 1981; 4(4):197-201. PubMed ID: 6796770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.
    Zegers BJ; Stoop JW
    Clin Biochem; 1983 Feb; 16(1):43-7. PubMed ID: 6407780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe combined immunodeficiency disease with adenosine deaminase deficiency.
    Yokoyama S; Hayashi T; Yoshimura Y; Irimada K; Saito T; Akiba T; Tsuchiya S
    Tohoku J Exp Med; 1979 Oct; 129(2):197-202. PubMed ID: 494270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.